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Abstract
In less-resourced settings, adverse pregnancy outcome rates are unacceptably high. To effect improvement, we
need accurate epidemiological data about rates of death and morbidity, as well as social determinants of health
and processes of care, and from each country (or region) to contextualise strategies. The PRECISE database is a
unique core infrastructure of a generic, unified data collection platform. It is built on previous work in data
harmonisation, outcome and data field standardisation, open-access software (District Health Information System 2
and the Baobab Laboratory Information Management System), and clinical research networks. The database
contains globally-recommended indicators included in Health Management Information System recording and
reporting forms. It comprises key outcomes (maternal and perinatal death), life-saving interventions (Human
Immunodeficiency Virus testing, blood pressure measurement, iron therapy, uterotonic use after delivery,
postpartum maternal assessment within 48 h of birth, and newborn resuscitation, immediate skin-to-skin contact,
and immediate drying), and an additional 17 core administrative variables for the mother and babies. In addition,
the database has a suite of additional modules for ‘deep phenotyping’ based on established tools. These include
social determinants of health (including socioeconomic status, nutrition and the environment), maternal co-
morbidities, mental health, violence against women and health systems. The database has the potential to enable
future high-quality epidemiological research integrated with clinical care and discovery bioscience.
Keywords: Open-source, Pregnancy, DHIS2, Placental disorders, eRegistry
Background
In less-resourced settings and particularly in sub-
Saharan Africa, adverse pregnancy outcome rates are un-
acceptably high. This is reflected in global estimates of
maternal mortality of 216/100,000 live births (2016 esti-
mates), stillbirths of 18.4/1000 live births (2015 esti-
mates), and neonatal mortality of 18.0/1000 live births
(2017 estimates) [1–3]. While estimates of near-miss
morbidity for mothers and newborns are thought to be
eight-fold higher [4, 5], there is no widespread routine
collection of relevant outcome data as there is for mor-
tality that allows for more accurate estimates globally, by
region, and over time. Also, there is little data on health
care quality and access to procedures that have the po-
tential to improve these outcomes.
To effect improvements in maternal, newborn, and child
health (MNCH) outcomes, we need accurate epidemio-
logical data about rates of death and morbidity, as well as
the social determinants of health and processes of care.
These data are needed from each country (and ideally
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region) to contextualise strategies. This is particularly im-
portant as countries are in different stages of the obstetric
transition, with different health care infrastructures and
priority needs [6]. Obtaining these data is currently ham-
pered by numerous practical barriers, including a lack of
standardisation of the predictor and outcome variables
collected and their definitions [7]. There is keen interest
in open-source software platforms, [8] self-programming
and database revision.
The PRECISE (PREgnancy Care Integrating translational
Science, Everywhere) Network is funded to collect epi-
demiological data and biological samples from women
and babies in western (The Gambia), eastern (Kenya), and
southern (Mozambique) sub-Saharan African countries.
The aim is to understand, in the African setting, the pre-
dictors of placental disorders (hypertension, fetal growth
restriction, and stillbirth) and determinants of their prog-
nosis. The project will ‘deep phenotype’ around 10,000
pregnant women (and their babies), approximately 1500
of whom we anticipate will experience a pregnancy com-
plicated by one of the placental disorders of interest (as
above). (We will also collect data on around 1800 non-
pregnant women of reproductive age as a control group.)
We have designed the PRECISE database with the fol-
lowing needs of the global research community in mind:
(i) the movement away from purpose-built project data-
bases so as to contain costs (initial and maintenance) and
facilitate data-sharing [9]; (ii) the need for strategic sup-
port for large-scale, high-quality, epidemiological research;
(iii) the desire to capitalise on the ubiquitous use of mobile
technology for data collection in facility and in commu-
nity; and (iv) the desire for open-access resources. We
have built on previous work in outcome standardisation
(by the International Consortium for Health Outcomes
Measurement, ICHOM); data harmonisation (by the Glo-
bal Pregnancy Collaboration, CoLab); the Manhiça Health
and Demographics Surveillance System (HDSS), and an
open-source, web-based health management information
system (HMIS) platform (by the Norwegian Institute of
Public Health).
In this manuscript, we describe our data collection plat-
form of core and supplementary modules, with the poten-
tial to be used for high-quality epidemiological research. It
is a single electronic repository of information (i.e. eRegis-
try) that can be shared by health system administrators,
clinicians, clinical investigators, and discovery scientists
through links with a laboratory information system.
Methods
Given the focus of the PRECISE Network on placental dis-
orders, the starting point was the CoLab ‘s COLLECT
database, designed for global studies in pre-eclampsia
[10]. COLLECT’s minimal and comprehensive data sets
were reviewed for their appropriateness for data collection
in our study sites, in terms of fields, definitions, and com-
prehensiveness for the purposes of the deep-phenotyping
to be undertaken in PRECISE [11]. Also, we reviewed the
software platform and connectivity requirements as we
knew internet access to be intermittent.
In anticipation of the need for additional content and
to enhance future usability, globally-recommended indi-
cators in health management information systems for
MNCH were identified and included, as component
parts of key definitions (such as gestational age and
blood pressure [BP] values), rather than reportable indi-
cators that may require interpretation or judgement
(such as a diagnosis of gestational hypertension) [12].
Variables were supplemented by review of the existing
standardised data collection forms in each study site, for
antenatal care (ANC), delivery, and ward care (antenatal
or postnatal).
The content of supplementary modules was based on the
holistic data needs of PRECISE (Fig. 1). These included the
social determinants of health (e.g., socioeconomic status,
Fig. 1 PRECISE holistic approach to pregnancy research
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air quality, geography, or nutrition); maternal pre-existing
and infectious co-morbidities; maternal mental health; and
elements of health systems’ strength (related to access, bar-
riers, and quality of care). Standardised tools were identi-
fied whenever possible to address each of these data
collection needs, based on needs-driven literature review
(e.g., for maternal morbidity) and the experience of the
PRECISE Network investigators.
The collection of biological specimens is recorded on
an affiliated laboratory information management system
(LIMS) described elsewhere. (For details of Baobab
LIMS, please see Craik et al. Reprod Health 2019, in
press [13].)
Results
The PRECISE protocol specifies prospective data collec-
tion into the PRECISE database, as pregnant women are
enrolled at facilities for: (i) routine ANC (i.e., ≈10,000
unselected pregnancies); or (ii) care of a placental dis-
order that is the focus of PRECISE (i.e., pregnancy
hypertension, suspected fetal growth restriction [FGR],
or intrauterine fetal death/stillbirth) if not already en-
rolled in PRECISE at that facility (i.e., ≈1500 women).
(Additional control women of reproductive age will be
enrolled when they present for contraceptive counselling
or in the company of another person who is presenting
for ANC or other care (i.e., ≈1800 women of reproduct-
ive age); in the Gambia, women of reproductive age will
be recruited in the community.) [(For details of PRECISE
Protocol, please see von Dadelszen et al. Reprod Health
2019, in press [14].) A project-specific eligibility screen-
ing has been designed to guide the study staff through
the details of participant selection and data collection,
documenting all information that would normally be re-
corded on a paper screening log, and eliminating the
need for the study staff to carry paper guidance.
Depending on the site, not all staff have clinical train-
ing. However, all have been trained on the content and
structure of the database, housed on android tablets (as
described below). The sequence of data collection fol-
lows the flow of women through the clinic care system
as much as possible.
Data fields
In choosing the content of the PRECISE database, we
reviewed all variables in the COLLECT ‘minimal’ or core
data set and the ‘comprehensive’ version of the database.
We supplemented our review with other MNCH instru-
ments for measurement of demographics, pre-pregnancy
health or obstetric history, processes of care, or outcomes.
The 923 variables in PRECISE were organised according
into the following modules: (i) general visit information,
including identifiers and geoinformatics variables of rele-
vance; (ii) baseline demographics and social determinants
of health; (iii) past medical and obstetric histories; (iv) nu-
trition, an additional social determinant of health; (v)
current pregnancy details, including addiction and mater-
nal mental health; (vi) details of assessments of pregnancy
hypertension, FGR, and intrauterine fetal death (IUFD)/
stillbirth; (vii) labour and delivery outcomes; (viii) mater-
nal and newborn outcomes; and (ix) postpartum health
and health care (Table 1). (Further details about the ori-
gins of each variable in each module are contained in
Additional file 1, Tables S2A to S2N.)
The modules have the flexibility to be be grouped ac-
cording to the data collection processes for PRECISE:
screening, PRECISE visit 1, PRECISE visit 2, information
from other ANC visits, pregnancy outcomes (birth, ma-
ternal, and newborn), and details of presentation with
placental disease (as relevant) or with laboratory results
(as applicable at any visit), as shown in Table 2.
The 25 core components are focussed on intrapartum
and immediate postpartum care as the time when most
adverse outcomes cluster. The components would be ap-
propriate for future use as screening data collection and
would impose the lowest burden on the health system.
These cover globally-recommended indicators in na-
tional HMIS recording and reporting forms, as per a re-
view of data elements related to maternal and newborn
health that were captured at different levels of the health
system by HMIS tools from 14 USAID priority countries
[12]. These core components consist of: (i) key mortality
outcomes, of maternal death, stillbirth, and neonatal
death (early and late); and (ii) life-saving interventions,
of Human Immunodeficiency Virus (HIV) testing, BP
measurement, iron therapy, uterotonic use after delivery,
postpartum maternal assessment within 48 h of birth,
and newborn resuscitation, immediate skin-to-skin con-
tact, and immediate drying. Additional variables
complete the 17 core administrative variables for the
mother and baby. For the mother, these are: maternal
age, parity, weight, substance use, need for intensive care
as reflected by maternal near-miss morbidity, transfusion
of blood products, and maternal length of stay. For the
baby (ies), the core administrative variables are: spontan-
eous or iatrogenic preterm birth, sex, birthweight, birth
injury, and obvious major birth defects and broad type),
as well as location and mode of delivery [44]. These out-
comes were developed by the ICHOM. To date, we have
not included patient-reported health status, satisfaction
with care, health care responsiveness, and birth experi-
ence, all of which would require specific data collection
tools and be hampered by low health literacy at our
study sites.
Given the deep-phenotyping mandate of PRECISE,
these core components were supplemented by additional
variables suitable for the immediate purpose of deep-
phenotyping in PRECISE, as well as for future use in
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different locations (depending on needs and interest) or
at different times (to monitor trends, depending on re-
gional/national/global needs). The variables were defined
according to various context-specific sources. COLLECT
definitions were used whenever possible, for the 60/923
variables shared with the COLLECT minimal dataset;
however, definitions were not always deemed feasible to
use from COLLECT given response options that were
not appropriate for our study settings (e.g., ethnicity cat-
egories that could not be mapped to context-specific op-
tions), unavailability of the intervention (e.g., invasive
prenatal diagnosis), and/or the absence of robust clinical
Table 1 Content of modules
Modules Description and tools
General visit information) Identifiers for future contacta, including Health Demographic Surveillance System (HDSS) numbers, as
relevant
Geo-informatic variables of relevance, including from where the woman travelled to seek care, and how that
travel was achieved (as performed in the Community-Level Interventions in Pre-eclampsia [CLIP] Mozambique
Trial) [15, 16]
Baseline information & social
determinants of health
Maternal demographics and pre-existing morbidities (Demographic Health Survey 7 [17], COLLECT database
[11], and CLIP trials [18], informed by regionally-appropriate tribal categories in The Gambia, Kenya, and
Mozambique
Grameen Poverty Probability Index for Senegal (as a surrogate for The Gambia for which there is none),
Kenya, and Mozambique [19]
UN International Fund for Agricultural Development Multidimensional Poverty Assessment Tool, MPAT [20]
Education and occupation (as in the CLIP trials [18])
Social supports and transport (as in the CLIP trials [18])
Joint Monitoring Programme on Water Supply and Sanitation (JMP), WHO and UNICEF Multiple Indicator
Cluster Surveys (MICS)- Household Questionnaire 2017 [21]
Past medical and obstetric histories COLLECT [11]
CLIP trials [18]
Demographic Health Survey 7 [17]
Nutrition Dietary Diversity Score from the Healthy Life Trajectories Initiative (HeLTI) [22]
Current pregnancy details COLLECT [11]
CLIP trials [18]
WHO recommendations on antenatal care for a positive pregnancy experience, 2016 [23]
Maternal Death Notification Form – South Africa 2014 [24]
Maternal mental health (WHO Maternal Woice Tool – antenatal care [25])
Details of placental disorders COLLECT [11]
CLIP trials [18]
fullPIERS [26] and miniPIERS [27, 28] predictive models of adverse maternal and perinatal outcome in pre-
eclampsia
Details of stillbirth in INDEPTH standardised verbal autopsy tool [29]
Labour and delivery COLLECT [11]
CLIP trials [18]
Adverse maternal outcome by Delphi consensus (fullPIERS [26] and iHOPE [30])
World Health Organization. WHO Recommendations on Antenatal Care for a Positive Pregnancy Experience.
Geneva, Switzerland: World Health Organization, 2016 [23]
Preterm birth phenotype [31]
Intergrowth-21 standards for weight at birth [32]
Averting Maternal Death and Disability (AMDD) Needs Assessment Toolkit: Modules 9 (Chart review for
women with obstetric complications) and 10 (Chart review of newborn mortality) [33]
ICD-MM [International Classification of Disease-Maternal Mortality (ICD-MM [34])
Maternal Death Notification Form – South Africa 2014 [24], Kenya 2017 [35]
WHO 2011 Maternal Near-Miss Morbidity Approach [4] informed by an African Delphi Consensus process [36]
WHO verbal autopsy tool for stillbirths [37], INDEPTH Standardized Verbal Autopsy questionnaire [29]
International Classification of Disease-Perinatal Mortality (ICD-PM [38]
Ministry of Health Perinatal Death Review Form – Kenya (2017)
WHO Making Every Baby Count initiative [39]
Maternal and newborn outcomes
Postpartum health Post-traumatic Stress Disorder Checklist-Civilian Version, PCL-C [40]
WHO Maternal Woice tool – postnatal care [41] (for mental health, violence against women and other
maternal morbidity)
WHODAS tool 2.0 [42] (health functioning)
EN-SMILING tool [43] (early childhood development and infant nutrition)
DHS-7 (also infant nutrition) [17]
a To be stripped by encryption when data are transmitted to the central servers at UBC
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records (e.g., family history of pre-eclampsia). A particu-
lar concern was the use in COLLECT of some over-
arching stem questions (such as occurrence of “maternal
morbidity”) that relied on high health literacy of the data
collectors who only if answering ‘yes’, would see ques-
tions about specific morbidities; health literacy is vari-
able among women, care-providers, and data collectors
in our study settings. In contrast, we focussed on clinical
data that care-providers routinely document, not “re-
portable indicators”; for example, care-providers record
the BP measurement and use the system-generated date
and gestational age to autogenerate a diagnosis of gesta-
tional hypertension at 20 weeks. This general principle
was respected throughout, such as for maternal and neo-
natal near-miss morbidity [4, 5, 45].
To ensure high-quality of data, programme rules were
added to implement skip-logics and cross-validation
rules for checking inconsistencies in real time. Each
module has a ‘See details’ option, the programming of
which is customised to provide the key details of rele-
vance to the user.
The woman’s study identifier is used to link her
epidemiological data with biorepository samples
tracked in Baobab LIMS, the LIMS chosen for the
project given it is open-source and its development
to facilitate harmonisation of biobanks across Africa,
our geographical focus. In this way, a participant’s
personal health information is not attached to any
specimen in the Baobab LIMS database. Executable,
customised programmes have been created to be run
periodically by the data manager to transmit bio-
banking core data into the database. (For details of
Baobab LIMS, please see Craik et al. Reprod Health
2019, in press [13].)
Table 2 Presentation of data collection in PRECISE database
Icons in PRECISE (DHIS2)a Timing of data collection Applicable modules
Screening (eligi-bility & data collection (each visit) (Study or setting-specific)
PRECISE visit 1 • General visit information
• Baseline demographics and social determinants of health
• Past medical and obstetric histories
• Nutrition
• Current pregnancy details
PRECISE visit 2 • General visit information
• Current pregnancy details
Other ANC visit (each) • Current pregnancy details (basic)
Birth (labour and delivery, maternal and baby outcomes) • Labour and delivery
• Maternal and newborn outcomes
Presentation with placental disease (any visit) • Details of placental disorders
Laboratory results (any visit) (Relevant to all modules at any visit)
a The REDCap interface has a ‘select event’ list
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Software
The PRECISE database is based on the District Health In-
formation System 2 (DHIS2) software and its application,
Tracker. First, DHIS2 is widely used (by 67 low and
middle-income countries) and, importantly, has been im-
plemented in the Palestinian Territories as the national
eRegistry for maternal and child health [46]. The Tracker
application provides capacity for individual-level data
entry. Second, Tracker is flexible, easily set-up, open-
source, and accessed using a variety of tools, including an-
droid tablets and smartphones, to maximise flexibility of
data collection at service delivery points [47]. If internet
connectivity is lost, work can continue offline to facilitate
efficient and effective data management. There is a ‘share’
function that generates a QR code (i.e., a machine-
readable optical label that contains the relevant informa-
tion about a PRECISE participant) that, if scanned by an-
other device, will transfer the woman’s information to
another PRECISE tablet, allowing for data collection with-
out interruption. Finally, the mandate of PRECISE in-
cludes capacity-building in Africa, and DHIS2 Tracker has
the greatest potential to form the basis for an eRegistry.
DHIS2 is packaged as a standard Java Web Archive file
and runs on any Servlet container with Java Runtime En-
vironment version 8 or higher installed, including the
need for a web server and a database server with sufficient
memory and storage space. As the preferred software en-
vironment for production server, Ubuntu 16.04 LTS oper-
ating system, PostgreSQL database and Tomcat Servlet
are recommended. Training materials have been written
so that those entering data have requisite skills to ensure
accuracy [47].
Other software was considered. We found the structure
of the COLLECT database challenging for the purposes of
PRECISE. First, we had available to us either all of the field
labels (variables and their characteristics) in the minimal
dataset (i.e., ≈500) or all in the comprehensive dataset (i.e.,
≈5000), but neither approach was realistic due to chal-
lenges with individual variables, as outlined above. Second,
the MedSciNet software required continuous connectivity
for data entry, but this is not available at our sites. We
considered Open Data Kit, a mobile data management ap-
plication that has been widely deployed in more than 130
countries [48]; however, the application (app) cannot han-
dle frequent changes to the data model and we sought a
resilient system for future use [49]. We considered Open
Medical Record System, created as an open-source health
software for low-resource settings [50]; while widely-used
for HIV care, this is not the case for antenatal and postna-
tal care of mothers and babies. Finally, we considered Re-
search Electronic Capture (REDCap) software, as it is
widely used and open-access; however, REDCap does not
have a personal dashboard, may not support well repeat-
able instruments and events, and the website has only a
report tool with filters, rather than analytical tools needed
for future functionality.
We did experience difficulties with the very large
volume of questions to be asked in PRECISE which
caused the DHIS2 Android Capture app to perform
very slowly; a work-around was created to decrease
the volume of data collection associated with any one
‘icon’ (as in Table 2), and this dramatically improved
speed. However, in testing, the software was still not
syncing 100% of all data entered, a problem experi-
enced by other software users. In addition, the per-
sonal dashboard of a participant across multiple
programmes (or tiles) was not always updated auto-
matically if it was not opened in a programme. Given
our need to start PRECISE data collection, we opted
to begin on REDCap software that is compatible with
the technical specifications of DHIS2 with which it
has a similar look and feel (Fig. 2). Further testing
will determine whether we revert to direct use of
DHIS2, or remain with the REDCap interface.
In the PRECISE database, all participants are given a
unique study identifier. Personal information is collected
and held on a local database kept in a locked environ-
ment, with direct access restricted to authorised individ-
uals who are responsible for monitoring and backing up
the system. All other access to the database is controlled
by logical security with access control and across a
standard secure Hyper Text Transfer Protocol Secure
network protected by a firewall and system controls with
authentication, role-based authorisation, and audit trails.
Strong password policies include password length and
complexity restrictions. All database back-ups are
encrypted and local Information Technology security
policies and procedures followed.
Data collection tablets are password-protected and
back-ups are encrypted. Each user logs into the app
with a strong username and password, ensuring the
study participant’s confidentiality even with loss of
tablets. Data are synchronised with local servers via
secure connections, preferably daily. To ensure confi-
dentiality, only authorised staff have access to per-
sonal information to facilitate data collection and
cleaning. Loss or damage of a tablet that results in
loss of data would be reported immediately. Informa-
tion would be erased before any damaged tablets
were recycled. Only password-protected computers
running an antivirus program are used to download
and process personal information for data linkage
and cleaning.
All data are stored locally on high capacity servers
stored in locked rooms. Extra measures for security in-
clude auxiliary power and continuous system monitor-
ing. A tape back-up system is used for the database (and
website).
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A copy of all de-identified qualitative, clinical,
geo-informatic, and laboratory data are stored on a
remote server located at the British Columbia
Children’s Hospital Research Institute with daily
backup and management by the PRE-EMPT team
(PREgnancy Evidence, Monitoring, Partnerships and
Treatment) at the University of British Columbia
(UBC). Data are stored on a secure database on a
high-speed network with access control, and servers
are stored in a secure locked server room with re-
stricted access to authorised system administrators.
When data are sent for merging with master
databases, research staff will keep a copy on their
restricted network drive. The final dataset along
with hard copies of results will be kept for at least
10 years.
For PRECISE, in each country, the database system is
hosted and managed by local IT system administrators
who are responsible for network security and access
control, system updates, database back-up and recovery,
and the in-country computer updates, in compliance
with local IT network, system, and security policies. The
data manager has set up and configured the database,
tested the system functionalities, updated ‘meta-data’
(that help users find relevant information within the
database), and installed/configured mobile apps on the
tablets. The data manager is responsible for importing
and exporting data, monitoring data updates, audit trails
and reports, and resolving data queries within the study
team.
It is the duty of sites to ensure data collected are
complete and accurate and to run validation rules. Data
Fig. 2 Interfaces for (a) DHIS2 Tracker and (b) REDCap
Magee et al. Reproductive Health 2020, 17(Suppl 1):50 Page 7 of 13
are queried periodically by the local data manager to
check for timely data collection and synchronisation,
missing information, and discrepancies. Only de-
identified data will be transmitted to the UBC central
database, preferably on a weekly basis, through a secure
connection with 256-bit Secure Sockets Layer encryp-
tion. At UBC, data queries are run and a query report
with feedback provided to each site’s local data man-
agers. The data query report focusses on missing values
without reasonable comments, out-of-range values, and
data inconsistencies that violate validation rules. The re-
port is designed to be reviewed and the queries resolved
with the local team. Built-in audit trails provide histor-
ical records of data-update activities.
Compliance with General Data Protection Regula-
tion (GDPR) is reliant on both the database and the
operational policies, procedures and processes of the
local study teams, to ensure that the necessary steps
are taken to: obtain appropriate informed consent for
data management (including collection, retention,
sharing, disposal, and dispute); staff training; designa-
tion of a Data Protection Officer; tablet protection;
server/platform protection; and detection and report-
ing of breaches. In addition, consent to participate in
any project involving the database must protect par-
ticipants’ eight individual rights under GDPR to: be
informed, access, rectification, withdrawal of consent,
erasure, restriction of processing (of data), data port-
ability, and objection.
Challenges
Our challenge related to our planned software platform,
DHIS2, has been discussed above. Additional challenges
relate to implementation of database content.
First, the World Health Organization (WHO) ANC
guidelines recommend that, “Health-care providers
should ask all pregnant women about their tobacco
use (past and present) and exposure to second-hand
smoke as early as possible in the pregnancy and at
every antenatal care visit”, and, “Health-care pro-
viders should ask all pregnant women about their
use of alcohol and other substances (past and
present) as early as possible in the pregnancy and at
every antenatal care visit” [23]. Our in-country teams
customised these questions to deal with cultural
sensitivities.
Second, given the critical importance of mental
health in pregnant and postpartum women, we had
planned to integrate the WHO ‘WOICE’ tool for
measurement of maternal morbidity, to which we
added a scale of post-traumatic stress disorder [25,
41]. However, in-country teams were not comfortable
due to the lack of both privacy in which to ask and
answer these questions in the ANC setting, as well as
the lack of well-established care pathways for women
identified as having issues or being at high risk; ante-
natal and postnatal modules containing these ques-
tions are currently offline while we undertake care
pathway mapping to prepare for the inclusion of
these questions during the course of the project.
Discussion
The PRECISE database as designed is a unique infra-
structure of a generic, unified data collection plat-
form of core and supplementary variables that cover
globally-recommended indicators included in HMIS
recording and reporting forms, comprised of: key
outcomes, life-saving interventions, and an additional
17 core administrative variables for the mother and
babies. In addition, the database has a suite of add-
itional variables designed for ‘deep phenotyping’ re-
lated to the placental disorders of hypertension, FGR,
and stillbirth, but which are widely applicable for
studying pregnancy-related conditions: social determi-
nants of health, maternal co-morbidities, nutrition,
mental health and domestic violence. The data ele-
ments and definitions have been standardised to
comply with existing data dictionaries and/or tools,
from international clinical, research, and policy orga-
nisations, including the WHO, as well as efforts for
international outcomes standardisation. The software
platform is DHIS2, which is open-access and sup-
ported by free programming training by the Univer-
sity of Oslo as a WHO Collaborating Centre.
Strengths and limitations
Data collection at the point of clinical care is enabled by
the modular structure of the PRECISE database. This ap-
proach to an electronic health record is both longitu-
dinal and truly prospective, so collection of relevant
clinical data will precede outcomes, which means that
they cannot be biased by those outcomes. Specifically,
predictors will be collected prior to occurrence of a pla-
cental disorder, and a placental disorder prior to the oc-
currence of maternal and perinatal mortality and
morbidity. This is critical to understanding the epidemi-
ology and true denominator and numerator of adverse
outcomes, such as stillbirths, a major contributor to lives
lost in Reproductive MNCH (RMNCH).
DHIS2, on which Tracker is programmed, is sus-
tainable. The core software development team is
hosted as a “global public good” at the University of
Oslo, a world leader in HMIS strengthening in less-
developed countries; DHIS2 has been implemented,
at least regionally, in 87 countries and Indian states,
with 53 operating at national scale. The University of
Oslo also contributes by offering in-country capacity
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building and implementation support and research,
and as a WHO Collaborating Centre for Innovation
and Implementation Research.
Limitations of the PRECISE database include how
the questions must be structured; any responses for
which ‘mark all that apply’ is appropriate must be
phrased as different questions. Fields cannot currently
be auto-filled from earlier data entries on the An-
droid app; for example, if a woman has indicated that
she is HIV positive on a previous form, Tracker will
not automatically fill in later fields recording her HIV
status. Also, images from supporting documentation
(such as visual aids to describe sanitation facilities)
cannot currently be uploaded and stored on the
DHIS2 Android app. There is no offline data capture
app that is supported on an Apple operating system
device; however, the platform can still be accessible
via internet through Safari or Chrome browsers if in-
stalled on an Apple device.
The literature
The WHO promotes client registry-based health in-
formation systems as one of the most promising ave-
nues to support quality universal health coverage in
RMNCH. While most less-developed countries have
national eHealth plans, a lack of harmonisation and
capacity-building risks squandering opportunities for
research and collaboration.
A standardised approach to RMNCH data field
collection is critical. Measurement strategies must
be consistent across communities and countries,
and over time, in order to benchmark and address
underlying differences, improve outcomes and re-
duce disparity. The Bill & Melinda Gates Founda-
tion (BMGF)-funded Healthy Birth, Growth, and
Development – knowledge integration initiative is as-
sembling ‘big data’ and novel analytic data rallies
(focussed analytic efforts) from more than 170
BMGF-funded projects, involving ≈12 million sub-
jects from 34 countries, to inform key questions in
child health and development [51]; the investigators
will drill down through masses of data looking for
patterns, statistical anomalies, and other newly dis-
covered facts to inform new hypotheses in clinical
research, and fashion updated clinical guidelines
and protocols [52]. However, the initiative faces the
challenge of different data fields, with different defi-
nitions, and different platforms – the same chal-
lenge faced by individual patient data meta-analyses
in pregnancy. For example, in its synthesis of inter-
national angiogenic biomarker data (22 pregnancy
cohorts, 16,462 pregnancies), the BMGF-funded
CoLab estimates that more than 300 h were re-
quired to map data fields and definitions from one
cohort to another, in order to find common ground
on which to base the data synthesis [53].
Electronic health (eHealth) technology is the most
frequently cited opportunity for maternal health
among international researchers [54]. eHealth has
been described as the … use of information and
communications technologies in support of health
and health-related fields, including health care ser-
vices, health surveillance, health literature, and health
education, knowledge, and research [52]. At a global
level, health data may: (i) not be captured at all; or
if collected, (ii) captured but multiple times in mul-
tiple ways, or (iii) captured but in a way that cannot
be shared due to interoperability issues or a lack of
standardised definitions. This is not surprising given
that approximately half of all referral facilities rely
on paper data management [30]. The implications
are illustrated by estimates of the maternal mortality
ratio (per 100,000 live births) in Lesotho that vary by
over 10-fold depending on the data source– 100/100,
000 based on their confidential enquiry into maternal
deaths, 500/100,000 according to entry of aggregate
data from a paper birth registry into DHIS2, and
1057/100,000 as reported by the Demographic Health
(household) Survey [Personal communication, B Pat-
tinson 2018 Oct 4].
Making data valuable to the collector is the key to
obtaining quality data, and lack of data use where it
is collected has been cited as the weakest part of
the HMIS in many countries [55]. In contrast, col-
lecting data at point-of-care, in an electronic record
with decision- and work-flow support, is designed
with care providers in mind as both users and
beneficiaries.
While many countries are implementing health regis-
tries in various forms, very few can act as an integrating
backbone for health information and bioscience, clin-
ical, and epidemiological research [56]. This is unre-
lated to the fact that the majority are in transition from
paper-based data to digital data collection systems, but
rather that even when fully implemented, the current
bespoke ‘top-down’ solutions may not capture locally-
relevant determinants of outcomes or be inter-operable
between countries. Additionally, local/regional ‘bottom-
up’ efforts or bespoke databases for specific research
projects are not standardised and thus, unable to moni-
tor national trends [52].
eRegistries are systems using information and com-
munication technologies for the systematic longitu-
dinal collection, storage, retrieval, analysis, and
dissemination of uniform information on the health
determinants and outcomes of individual persons, to
serve diverse stakeholders, including those providing
health care services or health surveillance, and those
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conducting research [56]. eRegistries are feasible and
have been successfully implemented in MNCH [56].
Most undertake duplicate data collection on paper
with transfer to an electronic database (e.g., Maternal
Newborn Health Registry of the National Institutes
of Health and BMGF-funded Global Health Net-
work). However, some countries (e.g., Kenya) have
published research based on primary data entry in
fully electronic registries at national or regional
levels, and individual records have also been linked
with laboratory tests and biorepositories [56, 57], and
a fully-functional eRegistry programmed on DHIS2
with decision support is currently being evaluated in
the Palestinian Territories [46].
The strengths and operational challenges of DHIS2
have been recently reviewed systematically, in 20
studies from 11 countries [47]. The most important
strengths were the technical features of the software
(e.g., open-source); proper management of data (e.g.,
data entry at point of service provision); and applica-
tion flexibility (e.g., ability to customise to meet local
needs and sustainability of software); all are being
leveraged in PRECISE. The most important oper-
ational challenges were management/leadership (e.g.,
proper planning for establishment) and training (e.g.,
of staff), sufficient workforce, appropriate communi-
cation infrastructure (e.g., internet), and the political,
cultural, social and structural infrastructure (includ-
ing linguistic challenges). All of these are being ad-
dressed in PRECISE, by staff hiring, training sessions
and materials, close supervision, provision of en-
hanced internet capabilities (although not continu-
ous), and a strongly supportive leadership, including
local governmental officials.
While follow-up in PRECISE is currently to 6 weeks
postpartum, it is critical to develop mechanisms to facili-
tate long-term follow-up. Conducting PRECISE in col-
laboration with the Manhiça Health Research Centre
affords us the opportunity to link our database with the
routine morbidity surveillance conducted for all children
under 15 years of age who attend for inpatient or out-
patient care in the area covered by their HDSS [58].
Finally, there is a need to understand which compo-
nent(s) of packages of care are key elements of suc-
cessful interventions. For example, the WHO eight-
contact ANC model includes health promotion and
nutritional interventions, and prevention and early de-
tection of selected pregnancy-related conditions and
concurrent diseases, including malaria, HIV, and tu-
berculosis. There are currently significant knowledge
gaps that impede optimisation of care, given: the
complexity of factors to consider; the need for coun-
tries to adapt recommendations based on their coun-
try context and populations’ needs; and the inability
of rigorous study methods (such as randomised trials)
to evaluate each individual component of such pack-
ages, particularly in various settings. However, the
volume and quality of data collected in an eRegistry
can facilitate an understanding of the effects of mul-
tiple mediators, while accounting for unobserved con-
founders, using a counter-factual approach with
multiple simulations from observed data, and boot-
strapping for confidence intervals. Taking the eight-
visit WHO ANC model, one could ask if it is neces-
sary to measure proteinuria at every ANC visit? Or,
what is the value of screening for hypertension at 32
weeks’ gestation, in relation to other potential media-
tors of any observed effect (Fig. 2)?
Conclusions
We seek to build on PRECISE (in Africa) and the eReg-
istry concept by developing a generic, unified data col-
lection platform that links clinical research and clinical
care, thereby creating both a ‘learning health system’ for
care-providers, and a monitoring, learning and evalu-
ation system for academics and health administrators.
Research could take the form of large-scale epidemio-
logical work, clinical trials, implementation science, or
discovery science by linking clinical data with stored bio-
logical samples logged in a LIMS system. Distributed
analytical software packages (such as DataSHIELD) can
now enable real-time, in-country analyses and research
collaborations. In addition, there is potential to integrate
decision support, facilitate remote access and analyses,
and replace manual aggregation of data from multiple
sources with electronically-generated reports for submis-
sion to central authorities, thus providing a mechanism
for governments and other international agencies to
monitor trends and identify priorities for more detailed
data collection.
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